Home › Funds › Prana Capital Management, LP › ELV
Prana Capital Management, LP position in ELV
ELEVANCE HEALTH INC FORMERLY · Health Care
Prana Capital Management, LP reported holding 62,368 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$24.2M, representing 0.82% of its reported portfolio and ranking #36 among its reported holdings. Prana Capital Management, LP has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Prana Capital Management, LP's ELV position evolved
Prana Capital Management, LP first disclosed a stake in ELV in Q3 2023 at 105,278 shares (US$45.8M). The position peaked in Q1 2026 at 229,145 shares, worth US$67.1M. Across 13 filings, Prana Capital Management, LP increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 62,368 shares valued at US$24.2M — a reduction of -93,374 shares quarter over quarter.. Notable position changes include a 107% increase in Q3 2024 (shares fell 29% over the following quarter), a 799% increase in Q3 2025 (shares rose 9% over the following quarter), a 1703% increase in Q1 2026 (shares rose 33% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 105.28K | $45.84M | New |
| Q4 2023 | 118.44K | $55.85M | Add |
| Q1 2024 | 67.39K | $34.94M | Reduce |
| Q2 2024 | 24.75K | $13.41M | Reduce |
| Q3 2024 | 51.22K | $26.63M | Add |
| Q4 2024 | 25.08K | $9.25M | Reduce |
| Q1 2025 | 3.56K | $1.55M | Reduce |
| Q2 2025 | 5.74K | $2.23M | Add |
| Q3 2025 | 51.63K | $16.68M | Add |
| Q4 2025 | 12.71K | $4.46M | Reduce |
| Q1 2026 | 229.15K | $67.08M | Add |
| Q2 2026 | 155.74K | $60.23M | Reduce |
| Q3 2026 | 62.37K | $24.25M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELV and 13F data
ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.31B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELV
- Wellington Management Group 9.21M sh · $3.56B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 8.52M sh · $3.31B · Q3 2026
- Sanders Capital, LLC 5.83M sh · $2.27B · Q3 2026
- Harris Associates (Oakmark) 4.92M sh · $1.90B · Q2 2026
- HARRIS ASSOCIATES L P 4.78M sh · $1.86B · Q3 2026
- First Eagle Investment Management 4.20M sh · $1.63B · Q3 2026
- Artisan Partners Limited Partnership 3.76M sh · $1.46B · Q3 2026
More on Prana Capital Management, LP
FAQ
How long has Prana Capital Management, LP held ELV?
Prana Capital Management, LP has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Prana Capital Management, LP's current position in ELV?
As of Q3 2026, Prana Capital Management, LP holds 62.37K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $24.25M, representing 0.82% of its reported portfolio and ranking #36.
Has Prana Capital Management, LP been buying or selling ELV?
In the latest 13F filing (Q3 2026), Prana Capital Management, LP reduced its position in ELV. The position peaked in Q1 2026 at 229.15K shares.
Which other funds hold ELV?
Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.